The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of a nurse monitoring service at preventing disease- or therapy-related symptoms in patients receiving targeted therapy or immunotherapy.
 
Andrea Sbrana
Honoraria - Novartis
Travel, Accommodations, Expenses - Pfizer
 
Andrea Antonuzzo
Honoraria - Springer
Consulting or Advisory Role - CD Pharma; Dompè
Speakers' Bureau - Janssen Oncology; MSD Oncology; Pfizer
 
Carla Ida Ripamonti
No Relationships to Disclose
 
Fausto Roila
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/UCB Japan (Inst); ERYTECH Pharma (Inst); Exelixis (Inst); Janssen (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Daniele Santini
No Relationships to Disclose
 
Alessandra Fabi
No Relationships to Disclose
 
Paola Ermacora
No Relationships to Disclose
 
Gianmauro Numico
No Relationships to Disclose
 
Raffaele Barbara
No Relationships to Disclose
 
Deborah Coletta
No Relationships to Disclose
 
Laura Velutti
No Relationships to Disclose
 
Domenico C. Corsi
No Relationships to Disclose
 
Alfredo Berruti
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi; Sanofi
 
Gabriella Mariani
No Relationships to Disclose
 
Paolo Bossi
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD Oncology; Regeneron
Consulting or Advisory Role - Angelini Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD Oncology; Sanofi/Regeneron; Sun Pharma
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD Oncology (Inst); Regeneron (Inst); Roche (Inst)